---
title: 'Medical Director, Global Drug Safety at Replimune'
canonical: 'https://feeny.ai/job/medical-director-global-drug-safety-replimune-woburn-h7cdcny6qz30'
type: 'job'
last_seen: '2026-09-16'
---

# Medical Director, Global Drug Safety at Replimune

- **Company:** Replimune
- **Location:** Woburn, MA
- **Employment:** full-time
- **Work type:** hybrid
- **Posted:** 2026-08-06
- **Last confirmed live:** 2026-09-16
- **Apply:** https://jobs.ashbyhq.com/replimune/52e1123a-9b87-4ae6-8b58-c8836b9477d3

## Job description

## Overview

Replimune’s mission is to revolutionize cancer treatment with therapies designed to activate a powerful and durable full-body anti-tumor response, boldly transforming cancer care because patient’s lives depend on it.

At Replimune, we live by our values:

United: We Collaborate for a Common Goal. Audacious: We Are Bold. Dedicated: We Give Our Full Commitment. Candid: We Are Honest With Each Other.

People are at the center of everything we do, and when it comes to our employees, we make it personal. With a deep sense of purpose, a strong and evolving culture, a competitive and forward-looking total rewards program, everyone at Replimune has a unique opportunity to impact on the lives of patients, caregivers and themselves.

Join us, as we reshape the future.

Summary of job description: The Medical Director, GDS&RM will perform individual and aggregate case reviews and provide broad support of activities requiring medical safety input for assigned products, both pre- and post-approval. The Medical Director, GDS&RM will support and/or lead periodic safety signaling reviews and meetings. This position will also participate, to varying degrees, on clinical teams/programs and other intra- and interdepartmental activities and initiatives, as needed.

- This position is based in our Woburn office and welcomes hybrid work! Local candidates are expected to be on-site a minimum of 2 days per week.

## Key responsibilities

- Provide timely and scientifically sound medical review of individual case safety reports from clinical trials and post-marketing sources.
- Serve as the GDS&RM medical expert for SAE reconciliation, coding reviews, and assessment of the expectedness of serious adverse reactions (SARs).
- Represent the department as the medical safety lead on cross-functional study and program teams for assigned products and studies, providing expert guidance on safety matters and issues.
- Represent the department as the subject matter expert (SME) during audits and inspections.
- Participate in protocol development, specifically regarding the monitoring and collection of safety information in clinical trial protocols, as well as statistical analysis plans.
- Conduct safety signal detection activities, including monitoring, evaluation, interpretation, management, and communication of safety information to the Safety Surveillance/Safety Management Team for assigned products. This includes leading ongoing and cross-functional benefit-risk assessments and related actions, as well as authoring and updating benefit-risk documents for assigned products and development compounds.
- Collaborate closely with Clinical Medical Monitors on ongoing safety monitoring and participate in the analysis of safety data from ongoing and completed clinical trials, including contributions to Clinical Study Reports.
- Work closely with the Medical Affairs team on post-approval product safety reports, investigator-sponsored trials (ISTs), and compassionate-use programs.
- Oversee the appropriate review of all safety data from various sources (e.g., preclinical studies, clinical trial data, and literature) throughout the development process for assigned products.
- Author Safety Assessment Reports and other safety-related documents and regulatory responses in collaboration with the Senior Director and Vice President, GDS&RM.
- Contribute to the preparation and review of periodic reports (e.g., IND Annual Reports, DSURs, PSURs, and CSRs).
- Review and provide medical input, as needed, for key study-related documents, including Investigator's Brochures (IBs), Informed Consent Forms (ICFs), and IDMC Charters.
- Participate in departmental development activities, including the creation and revision of SOPs and Work Instructions.
- Provide medical guidance to staff regarding best practices for the collection, evaluation, and processing of adverse event reports.
- Contribute to partner and affiliate agreements and interactions, as needed.
- As directed by management, assume primary responsibility for and/or chair one or more Safety Teams for assigned products.
- Participate in Risk Management Strategy activities.
- Perform other duties as assigned by management.

Other responsibilities

- Perform other related duties as necessary to meet the ongoing needs of the GDS&RM organization. Educational requirements:
- MD, DO or equivalent non-US medical degree. Experience and skill requirement:
- Strong knowledge of general medicine and clinical medical practice (MD, DO, MBBS, or equivalent).
- Strong understanding of disease pathophysiology and medical therapies.
- Working knowledge of GCP, ICH guidelines, and global regulatory requirements.
- Minimum of 5 years of experience in Drug Safety/Pharmacovigilance or as a Medical Monitor; experience in oncology and immunotherapy is preferred.
- Experience in the evaluation, analysis, and interpretation of safety data.
- Demonstrated ability to manage multiple priorities and responsibilities.
- Strong written and verbal communication skills.
- Sound judgment and decision-making abilities, including the timely identification and communication of relevant safety issues and concerns to Medical Safety Management.
- Experience reviewing AEs/SAEs, Investigator's Brochures, protocols, Clinical Study Reports, informed consent documents, and other safety-related materials.
- Strong attention to detail.
- Prior NDA/BLA submission experience and oncology experience are preferred Salary Range Replimune is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $257,500-$333,500. The exact base pay offered for this role will depend on various factors, including but not limited to the selected candidate’s unique set of qualifications, skills, and experience. Our current organizational needs also play a part in determining your final offer.

At Replimune, base pay is only one part of your total compensation package. The selected candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Replimune also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, flexible time off, and a number of paid holidays including year-end shutdown.

## About Replimune

Replimune Group, Inc., headquartered in Woburn, MA, was founded in 2015 with the mission to transform cancer treatment by pioneering the development of a novel portfolio of oncolytic immunotherapies. Replimune’s proprietary RPx platform is based on a potent HSV-1 backbone intended to maximize immunogenic cell death and the induction of a systemic anti-tumor immune response. The RPx platform is designed to have a unique dual local and systemic activity consisting of direct selective virus-mediated killing of the tumor resulting in the release of tumor derived antigens and altering of the tumor microenvironment to ignite a strong and durable systemic response. The RPx product candidates are expected to be synergistic with most established and experimental cancer treatment modalities, leading to the versatility to be developed alone or combined with a variety of other treatment options. For more information, please visit [www.replimune.com](http://www.replimune.com). We are an Equal Opportunity Employer.

## About Replimune

## Company Overview
- **One-liner**: Replimune is a clinical-stage biotech company focused on revolutionizing cancer treatment with a new class of oncolytic immunotherapies intended to activate a powerful and durable full-body anti-tumor response.
- **Entity Type**: Public (ticker not explicitly provided in search results, but company is publicly traded)
- **Headquarters**: Framingham, Massachusetts, USA (with additional locations in Woburn, MA and Oxfordshire, UK)
- **Founded**: 2015
- **Founders**: Robert Coffin, Ph.D. (Founder and Chief Scientist)

## Core Business
- **Primary industry**: Biotechnology – oncology, oncolytic immunotherapy
- **Target customers**: B2B (pharmaceutical partners) and ultimately patients through healthcare providers
- **Mission**: To ignite a systemic immune response to cancer and reshape the future of cancer care

## Products & Services
- **RPx Platform**: Proprietary, next-generation HSV-1-based oncolytic immunotherapy platform that powers all pipeline candidates.
- **RP1**: Investigational oncolytic immunotherapy for advanced melanoma (IGNYTE trial, PDUFA date April 10, 2026) and non-melanoma skin cancers; also being studied as monotherapy in organ transplant patients with skin cancer (ARTACUS trial).
- **RP2**: Investigational oncolytic immunotherapy for metastatic uveal melanoma (Phase 2/3 RP2-202 trial) and hepatocellular carcinoma (Phase 2 in combination with atezolizumab/bevacizumab).

## Market Standing
- **Valuation/Market Cap**: Not publicly available in provided sources
- **Key Metric**: Clinical-stage; no approved products yet. Key regulatory milestone: FDA action date for RP1 in advanced melanoma on April 10, 2026.
- **Notable Partners**: Bristol-Myers Squibb (supply of nivolumab), Roche (supply of atezolizumab and bevacizumab) – Replimune retains full commercial rights.
- **Growth Signals**: Completed enrollment in IGNYTE trial; confirmatory IGNYTE-3 trial underway; own 63,000 sq ft U.S. manufacturing facility in Woburn, MA enabling global commercial supply; broad pipeline across multiple solid tumor indications.

## Competitive Advantages
- **Strong IP position**: Wholly-owned, unencumbered RPx platform with broad patent protection.
- **In-house manufacturing**: Dedicated U.S. facility for commercial-scale production, reducing reliance on contract manufacturers.
- **First-mover potential**: Poised to be one of the first oncolytic immunotherapies to reach the market if RP1 gains FDA approval.
- **Full rights retained**: All partnership agreements allow Replimune to keep full commercial rights to its therapies.

## Strategic Focus
- Advancing RP1 toward FDA approval in advanced melanoma (April 2026 PDUFA date)
- Expanding pipeline into additional indications (uveal melanoma, hepatocellular carcinoma, non-melanoma skin cancers)
- Building out commercial infrastructure and manufacturing capabilities
- Exploring combination therapies with checkpoint inhibitors (nivolumab, atezolizumab)

## Why Work Here
- **Culture**: Cross-functional, collaborative, values-driven environment. Employee survey results show 92% proud to work at Replimune, 88% feel they make a positive difference, 78% would recommend the company.
- **Flexibility**: Hybrid and remote work options available depending on role; home office and mobile phone stipend provided.
- **Compensation**: New hire equity grants, generous annual bonus plans, retirement plans with substantial company match (100% vested from day one).
- **Benefits**: Medical, dental, and vision insurance 100% paid by the company.
- **Locations**: U.S. (Woburn, MA and Framingham, MA) and UK (Oxfordshire) – opportunities to work across both sites.

## Sources
1. [Replimune Homepage](https://www.replimune.com/)
2. [Replimune Careers](https://www.replimune.com/careers)
3. [Replimune About Us](https://www.replimune.com/about-us)
4. [Replimune Team](https://www.replimune.com/team)
5. [Replimune Pipeline](https://www.replimune.com/pipeline)

## Other roles at Replimune

- [Quality Control Technician](https://feeny.ai/job/quality-control-technician-replimune-milton-park-crdjs7tbkbj2) — Milton Park
- [Facilities Planning Manager II](https://feeny.ai/job/facilities-planning-manager-ii-replimune-framingham-00xc20kcgxp7) — Framingham, MA
- [Director, Qualified Person](https://feeny.ai/job/director-qualified-person-replimune-milton-park-75fmg67ccjnk) — Milton Park
- [Director, Information Technology](https://feeny.ai/job/director-information-technology-replimune-woburn-1mybctpvw619) — Woburn, MA
- [Regional Director - MSL East](https://feeny.ai/job/regional-director-msl-east-replimune-woburn-h9w2v92t3p10) — Woburn, MA
- [Director, HR Business Partner](https://feeny.ai/job/director-hr-business-partner-replimune-milton-park-z5a3s7k1jy7g) — Milton Park
- [Executive Director, Market Access and Value](https://feeny.ai/job/executive-director-market-access-and-value-replimune-woburn-nf352x5v48bh) — Woburn, MA
- [Scientist II, Quality Control](https://feeny.ai/job/scientist-ii-quality-control-replimune-framingham-sf1y1pmqxbjw) — Framingham, MA
- [Senior Manager, Data Management](https://feeny.ai/job/senior-manager-data-management-replimune-woburn-kesxh7s9ktmd) — Woburn, MA
- [Operational Excellence Lead I (PharmD)](https://feeny.ai/job/operational-excellence-lead-i-pharmd-replimune-woburn-xt9zv5h9hb19) — Woburn, MA